Chemistry: analytical and immunological testing – Involving iga – igd – ige – or igm
Patent
1987-06-25
1988-12-13
Marantz, Sidney
Chemistry: analytical and immunological testing
Involving iga, igd, ige, or igm
43524027, 436509, 436533, 436534, 436548, 436808, 436821, 436825, 935103, 935110, G01N 33546, G01N 33577
Patent
active
047910674
ABSTRACT:
An assay method and kit for a hapten such as theophylline employs a first, latex reagent and a second, antibody reagent. By using a monoclonal antibody of the IgA class in the second reagent, interference by patient rheumatoid factor is prevented.
REFERENCES:
patent: 4362531 (1982-12-01), de Steenwinkel et al.
patent: 4397960 (1983-08-01), Moussebois et al.
patent: 4427781 (1984-01-01), Masson et al.
patent: 4491632 (1985-01-01), Wands
patent: 4582810 (1986-04-01), Rosenstein
patent: 4645748 (1987-02-01), Hurwitz
patent: 4659659 (1987-04-01), Dwek
M. Zrein et al., "Quantitation of Rheumatoid Factors," J. Immun. Methods, vol. 87, pp. 229-237 (1986).
L. A. Borque et al., "Immunoassay of Rheumatoid Factor by Latex Particle Counting," Clin. Chem., vol. 33, No. 5, pp. 704-707 (1987).
Opheim et al., "Particle-Enhanced Turbidimetric Inhibition Immunoassay for Theophylline Evaluated with the DuPont aca", Clin. Chem. vol. 30, No. 11, pp. 1870-74 (1984).
Chan Teresa H.
Sheiman Mark I.
Yeung Kwok K.
Doernberg Alan M.
Fisher Scientific Co.
Marantz Sidney
LandOfFree
Agglutination immunoassay for hapten involving monoclonal antibo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agglutination immunoassay for hapten involving monoclonal antibo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agglutination immunoassay for hapten involving monoclonal antibo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2195956